Skip to main content

Advertisement

Log in

Polysaccharide-K (PSK) may suppress surgical stress-induced metastasis in rat colon cancer

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

We previously demonstrated that hepatic ischemia and reperfusion (I/R) injury increased liver metastasis and cancer growth of RCN-H4 cells. Using a rat model of hepatic I/R-induced liver metastasis, we investigated the metastasis-suppressing effect of polysaccharide-K (PSK), a biological response modifier composed of protein-bound polysaccharide.

Methods

Fischer rats underwent 60 min of 70% partial hepatic ischemia. After 60 min of reperfusion, rat colon adenocarcinoma cells (RCN-H4) were inoculated intrasplenically. PSK was administered orally before I/R, after I/R, or before and after I/R. The weights of metastatic lesions of the liver or the numbers of liver metastatic nodules were determined on day 21. The effect of PSK on angiogenesis was studied by a rat cornea model using RCN-H4 cells or a vascular endothelial growth factor (VEGF)-containing pellet and an in vitro VEGF-induced endothelial cell migration assay.

Results

PSK administration significantly (p < 0.05) suppressed the I/R-induced increase in hepatic metastasis of RCN-H4 cells. The suppression of I/R-promoted metastasis was observed irrespective of the timing of administration. Furthermore, PSK significantly suppressed angiogenesis induced by RCN-H4 cells (p < 0.05) and the VEGF pellet (p < 0.01). PSK significantly suppressed the VEGF-induced migration of vascular endothelial cells (p < 0.05).

Conclusion

PSK may suppress metastasis induced by hepatic I/R. The suppression of angiogenesis by PSK may be one of the mechanisms of the inhibition of hepatic metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tamagawa K, Horiuchi T, Uchinami M, Doi K, Yoshida M, Nakamura T, Sasaki H, Taniguchi M, Tanaka K (2008) Hepatic ischemia–reperfusion increases vascular endothelial growth factor and cancer growth in rats. J Surg Res 148:158–163

    Article  PubMed  CAS  Google Scholar 

  2. Doi K, Horiuchi T, Uchinami M, Tabo T, Kimura N, Yokomachi J, Yoshida M, Tanaka K (2002) Hepatic ischemia–reperfusion promotes liver metastasis of colon cancer. J Surg Res 105:243–247

    Article  PubMed  CAS  Google Scholar 

  3. Uchinami M, Muraoka R, Horiuchi T, Tabo T, Kimura N, Tanigawa N (1998) Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery 124:49–56

    Article  PubMed  CAS  Google Scholar 

  4. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 344:1122–1126

    Article  Google Scholar 

  5. Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, Nakamura S, Kakimura S, Iwazaki S, Ishikawa H, Kawate S, Nakajima T, Morishita Y (2004) Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomized controlled study. Br J Cancer 90:1003–1010

    Article  PubMed  CAS  Google Scholar 

  6. Konno K, Motomiya M, Oizumi K, Sato M, Yamamoto F, Tamiya K, Hasuike T, Yokosawa A, Ochiyama T, Ogawa N, Nakai Y (1988) Effect of protein-bound polysaccharide (PSK) in small cell carcinoma of the lung. JJLC 28:19–28

    Article  Google Scholar 

  7. Nomoto K, Tsuru S, Awane Y, Kamei H, Ishibiki H, Sekiguchi M, Tamada R, Toge T, Nakajima T (1986) Changes of nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy. Jpn J Cancer Chemother 13:458–463

    CAS  Google Scholar 

  8. Hirose K, Zachariae COC, Oppenheim JJ, Matsushima K (1990) Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. Lymphokine Res 9:475–483

    PubMed  CAS  Google Scholar 

  9. Liu A, Abrise J, Holmgren A, Klein G, Klein E (2005) PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. Blood 105:1606–1613

    Article  PubMed  CAS  Google Scholar 

  10. Kumar S, Saitoh K, Kumar P (1992) Antiangiogenesis strategies in cancer therapy with special reference to Krestin. In: Steiner R, Weisz PB, Langer R (eds) Angiogenesis: key principles-science-technology-medicine. Birkhauser Werlag, Basel, pp 463–470

    Google Scholar 

  11. Inoue Y, Kashima Y, Aizawa K, Hatakeyama K (1991) A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response. Jpn J Cancer Res 82:90–97

    Article  PubMed  CAS  Google Scholar 

  12. Volpert OV, Tolsma SS, Pellerin S, Feige J, Chen H, Mosher DF, Bouck M (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326–332

    Article  PubMed  CAS  Google Scholar 

  13. Karpoff HM, Tung C, Ng B, Fong Y (1996) Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity. Hepatology 24:374–379

    Article  PubMed  CAS  Google Scholar 

  14. Oka M, Hazama S, Suzuki M, Wang F, Shimoda K, Iizuka N, Wadamori K, Suzuki T, Attwood S (1994) Depression of cytotoxicity of nonparenchymal cells in the liver after surgery. Surgery 116:877–882

    PubMed  CAS  Google Scholar 

  15. Ku Y, Kusunoki N, Shiotani M, Maeda I, Iwasaki T, Tominaga M, Kitagawa T, Fukumoto T, Suzuki Y, Kuroda Y (1999) Stimulation of haematogenous liver metastases by ischaemia–reperfusion in rats. Eur J Surg 165:801–807

    Article  PubMed  CAS  Google Scholar 

  16. Suo J, Tanaka N, Hizuka A, Orita K (1994) Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK. Acta Medica Okayama 48:237–242

    PubMed  CAS  Google Scholar 

  17. Matsunaga K, Ohhara M, Oguchi Y, Iijima H, Kobayashi H (1996) Antimetastatic effect of PSK, a protein-bound polysaccharide, against the B16-BL6 mouse melanoma. Invasion Metastasis 16:27–38

    PubMed  CAS  Google Scholar 

  18. Wada T, Wakamatsu Y, Bannai K, Kato M, Oguchi Y, Matsunaga K, Ando T, Nomoto K (2002) Suppression mechanism of angiogenesis by PSK. Ann Cancer Res Ther 10:93–106

    CAS  Google Scholar 

  19. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H (2009) The role of vascular endothelial growth factor in wound healing. J Surg Res 153:347–358

    Article  PubMed  CAS  Google Scholar 

  20. Warzecha Z, Dembinsky A, Ceranowicz P, Dembinsky M, Kownacki P, Konturek SJ, Tomaszewska R, Stachura J, Hladki W, Pawlik WW (2004) Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGFb RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis. J Physiol Pharmacol 55:791–810

    PubMed  CAS  Google Scholar 

  21. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870

    PubMed  CAS  Google Scholar 

  22. Yoshida Y, Anand-Apte B, Zetter BR (1996) Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 113:57–64

    Article  Google Scholar 

Download references

Conflicts of interest

KT and TH have no potential conflicts of interest. TW, KB, and TA are employees of Kureha Corporation, but the study was conducted with scientific integrity and presents no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsuya Horiuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamagawa, K., Horiuchi, T., Wada, T. et al. Polysaccharide-K (PSK) may suppress surgical stress-induced metastasis in rat colon cancer. Langenbecks Arch Surg 397, 475–480 (2012). https://doi.org/10.1007/s00423-011-0896-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-011-0896-2

Keywords

Navigation